Gysin et al. showed that pharmacologic inhibition of RAF-MEK-ERK signaling in pancreatic cancer cells inhibits cell growth and results in G1 cell-cycle arrest through induced expression of p27Kip1[49]. This evidence concerns the gene MAP2K7 and familial pancreatic carcinoma.